Contact
/
Home
/
About
Team
Portfolio
Exit History
News
About
Team
Portfolio
Exit History
News
Advent Life Sciences
Advent Life Sciences
Page 5 of 25
<< Start
< Prev
1
2
3
4
5
6
7
8
9
10
Next >
End >>
28.06.2021
Amphista Therapeutics Expands Research Team by Appointing Martin O’Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry
Press Release
23.06.2021
Aleta Biotherapeutics and Cancer Research UK collaborate to advance blood cancer therapy into the clinic
Press Release
17.06.2021
Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board
Press Release
08.06.2021
Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors
In The News
14.04.2021
Highlight Therapeutics to present data from Phase 2 immunotherapy studies of liver metastases and melanoma data at AACR Virtual Annual Meeting 202
Press Release
14.04.2021
Aura Biosciences Announces Publication of Data in Cancer Immunology Research Supporting the Immune Mediated Mechanism of Action of the Virus-Like Drug Conjugate (VDC) Technology Platform with Broad Application in Cancer Treatment
Press Release
12.04.2021
Francesco Maria Lavino appointed Chief Executive Officer of F2G Ltd
Press Release
01.04.2021
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
Press Release
24.03.2021
Aura Biosciences Expands Executive Leadership Team with the Appointment of Mark De Rosch, Ph.D., as Chief Operating Officer
Press Release
22.03.2021
Aura Biosciences Announces Oversubscribed $80 Million Financing
Press Release
©2022 Advent Life Sciences